Note payable to DIRECTV
Bristol-Myers Squibb Note payable to DIRECTV increased by 11.2% to $19.34B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.9%, from $18.09B to $19.34B. Over 4 years (FY 2020 to FY 2024), Note payable to DIRECTV shows an upward trend with a 6.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase indicates higher short-term debt obligations to related parties, while a decrease reflects repayment or settlement of these specific liabilities. High levels may suggest reliance on related-party financing for working capital needs.
Detailed definition
This represents a short-term financial obligation owed to a related party, specifically categorized as a current liabili...
Peer comparison
Comparable to other 'Notes Payable to Related Parties' or 'Due to Affiliates' found in the current liabilities section of peer company balance sheets.
note_payable_directvHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.73B | $13.70B | $13.97B | $12.36B | $13.08B | $14.20B | $14.59B | $13.14B | $14.06B | $15.18B | $15.88B | $16.09B | $15.98B | $18.09B | $18.13B | $16.51B | $17.39B | $19.34B |
| QoQ Change | — | +7.6% | +2.0% | -11.6% | +5.9% | +8.6% | +2.7% | -9.9% | +7.0% | +8.0% | +4.6% | +1.3% | -0.7% | +13.2% | +0.2% | -8.9% | +5.3% | +11.2% |
| YoY Change | — | — | — | — | +2.8% | +3.7% | +4.4% | +6.3% | +7.5% | +6.9% | +8.9% | +22.5% | +13.7% | +19.2% | +14.1% | +2.6% | +8.8% | +6.9% |
Note payable to DIRECTV at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's note payable to directv?
- Bristol-Myers Squibb (BMY) reported note payable to directv of $19.34B in Q3 2025.
- How has Bristol-Myers Squibb's note payable to directv changed year-over-year?
- Bristol-Myers Squibb's note payable to directv increased by 6.9% year-over-year, from $18.09B to $19.34B.
- What is the long-term trend for Bristol-Myers Squibb's note payable to directv?
- Over 4 years (2020 to 2024), Bristol-Myers Squibb's note payable to directv has grown at a 6.6% compound annual growth rate (CAGR), from $14.03B to $18.13B.
- What does note payable to directv mean?
- A short-term debt obligation owed to a related business entity.